These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 10845738

  • 1. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE, Walker JK, Lott RS, Shaw R, Speth J, Marty KJ, Rutecki P.
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR, McKee JR, Hammer AE, Vuongc A.
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Pohl LR.
    Neurology; 2007 Oct 16; 69(16):1610-8. PubMed ID: 17938371
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
    Biton V, Di Memmo J, Shukla R, Lee YY, Poverennova I, Demchenko V, Saiers J, Adams B, Hammer A, Vuong A, Messenheimer J.
    Epilepsy Behav; 2010 Nov 16; 19(3):352-8. PubMed ID: 20937567
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S, Terczynski A.
    Seizure; 2000 Oct 16; 9(7):486-92. PubMed ID: 11034873
    [Abstract] [Full Text] [Related]

  • 13. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
    Carpay JA, Aalbers K, Graveland GA, Engelsman M.
    Seizure; 2009 Mar 16; 18(2):119-23. PubMed ID: 18760635
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE, Levisohn P, Gucuyener K, Mikati MA, Warnock CR, Conklin HS, Messenheimer J.
    Neurology; 2008 May 27; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P, Osborn M, Abou-Khalil B.
    Epilepsy Res; 2014 Nov 27; 108(9):1637-41. PubMed ID: 25205163
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
    McKee JR, Sunder TR, FineSmith R, Vuong A, Varner JA, Hammer AE, Barrett PS.
    Epilepsy Behav; 2003 Aug 27; 4(4):386-94. PubMed ID: 12899858
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.